From emerging biotech firms to the largest global pharmaceutical companies, IQVIA's CORE-powered Clinical Development approach helps you match the pace of innovation with integrated solutions, and gives you the flexibility to match capabilities precisely with research needs.
We’re committed to providing solutions that help you innovate with confidence, maximize opportunities, and ultimately drive patient outcomes forward. The IQVIA CORE can connect you to innovative trial solutions like precision site selection, centralized monitoring, automated safety case processing and global regulatory expertise.
Enhance patient safety and study quality by using data, analytics, and technology to monitor patient, site, and study performance with risk-based and centralized monitoring.
Use AI, machine learning, NLP and new technologies to streamline pharmacovigilance, improve efficiencies, reduce costs, and meet safety demands.
Navigate complex regulatory requirements with expert insights and bring transparency, efficiency and predictability to your regulatory affairs strategy.
Create transparency in your regulatory documents with a range of medical writing services that deliver quality and timeliness throughout your product development lifecycle.
Getting the right outcomes from your clinical trials is all about the data and insights they provide. Biostatistics in clinical trials isn’t just a necessity, it can be a real competitive advantage.
Assess your protocol against real world evidence using advanced analytics, and reduce the risk of costly amendments.
Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.
Identify the best performing sites for your trial in less time with new machine learning and predictive modeling methods.
Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.